Moreover, restrictions on cross-border collaborations between drug developers and academic institutions due to geo-political issues are hindering the innovation and development of new treatment options for sickle cell disease. https://logcla.com/blogs/422830/Sickle-Cell-Disease-Treatment-Market-is-Anticipated-to-Witness-High